drugset / Trial / NCT03216304

Safinamide Steady State Interaction With Rosuvastatin

NCT03216304

Phase 1 Completed 24 enrolled Cross Research S.A. Zambon SpA · collab
Non-randomizedCrossoverOpen-labelTreatment

Summary

To evaluate if safinamide at the steady state, obtained after multiple 100 mg once a day administrations, has an effect on the pharmacokinetics of rosuvastatin, concomitantly administered as a single 20 mg dose, with respect to the pharmacokinetics of 20 mg rosuvastatin administered alone.

Timeline

Start
2017-05-22
Primary completion
2017-07-06
Completion
2017-07-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg Oral
Subject Safinamide Small molecule 100 mg Oral

Indications

No indication recorded.